Followers | 9839 |
Posts | 260002 |
Boards Moderated | 4 |
Alias Born | 12/27/2006 |
Wednesday, May 19, 2021 5:14:20 PM
Link to Video - click here to watch the technical chart video
Recent IOVA News
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/22/2024 09:30:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:56:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:53:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:52:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:52:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:51:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:50:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 01:00:20 PM
- Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer • GlobeNewswire Inc. • 03/04/2024 11:30:00 AM
- Iovance Biotherapeutics to Present at Upcoming Conferences • GlobeNewswire Inc. • 03/01/2024 10:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:30:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:05:21 PM
- Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates • GlobeNewswire Inc. • 02/28/2024 09:01:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:53:39 PM
- Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024 • GlobeNewswire Inc. • 02/22/2024 01:45:21 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/21/2024 09:44:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 10:23:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:21:48 PM
- Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock • GlobeNewswire Inc. • 02/20/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:03:55 AM
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/16/2024 10:30:50 PM
- Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024 • GlobeNewswire Inc. • 02/16/2024 08:38:31 PM
- Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma • GlobeNewswire Inc. • 02/16/2024 08:19:51 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:16:06 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM